Home / Intelligence / Webinars / Business Development: Getting Pricing & Access Inputs Right
Available On Demand
Trinity invites life sciences executives to join us for a dynamic discussion on the most common high-impact challenges inherent in Business Development:
- What contributes to inaccurate pricing and market access assumptions in the quick-paced Business Development process?
- How do you de-risk pricing and access at each stage of the diligence process?
Chad Faulkner, Partner in Trinity’s Strategic Advisory practice, will host this session and moderate a panel with special guests Monica Martin De Bustamante—Senior Partner & Head of Evidence, Value, Access & Pricing (EVAP), Kyle Martin—Partner in Trinity’s Insights practice and Andreia Ribeiro—Associate Principal in the EVAP Practice.
Key Webinar Topics
- The vital need to make rapid, informed decisions on pricing and market access assumptions for Business Development forecasting models
- Best practice approaches to pricing and market access inputs into the Business Development process
Featuring
Mónica Martín de Bustamante
Senior Partner,
Evidence, Value, Access & Pricing
Chad Alan Faulkner
Partner
Kyle Martin
Partner
Andreia Ribeiro
Associate Principal,
Evidence, Value, Access & Pricing
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
White Papers
Predicting Winners: AI-Powered Portfolio Management
Can artificial intelligence and machine learning (AIML) be used to support portfolio decision-making across the life sciences industry? In this installment of our Industry Impact Series, we find that not only can the latest AIML techniques identify the drivers of success and failure in commercialization, but Trinity Life Sciences’ AI algorithm accurately predicts revenue outcomes for […]
Read More
Webinars
Health Equity in HTA Outcomes: Navigating the New Frontier
Available On Demand
Join Value, Access and Pricing experts as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.
Watch Now
Webinars
Trinity Annual Drug Index
Available On Demand
White Paper & On-demand Webinar: This report, the seventh in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the performance of novel drugs approved by the FDA in 2021, scoring each […]
Watch Now